Vitreous Level Of Tumor Necrosis Factor Alpha In Patients With Retinal Vein Occlusion

Clinical trial NCT05532475 · COMPLETED

Trial details

NCT number: NCT05532475
Sponsor: Kasr El Aini Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Retinal Vein Occlusion

Start date: 2022-03-12
Primary completion: 2022-10-20
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.